Therapeutic innovation in the European Union: Analysis of the drugs approved by the EMEA between 1995 and 2003

British Journal of Clinical Pharmacology

Volumn 59, Issue 4, 2005, Pages 475-478

  Motola, Domenico ^a   De Ponti, Fabrizio ^a,c   Rossi, Pasqualino ^b   Martini, Nello ^b   Montanaro, Nicola ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b MINISTRY OF HEALTH   (Italy)

^c Department of Pharmacology ^*  (Italy)

Author keywords

Biotechnological drugs; Drug evaluation; European centralised procedure; Theraputic innovation

Indexed keywords

AGALSIDASE ALFA; ALITRETINOIN; ANTIHYPERTENSIVE AGENT; BLOOD CLOTTING FACTOR; DRUG; ENFUVIRTIDE; ENTACAPONE; IMATINIB; IMIGLUCERASE; INFLIXIMAB; INSULIN; INSULIN GLARGINE; INSULIN LISPRO; PROTEINASE INHIBITOR; RALOXIFENE; RECOMBINANT GROWTH HORMONE; RECOMBINANT HUMAN INSULIN; REPAGLINIDE; RILUZOLE; RIVASTIGMINE; SILDENAFIL; TELITHROMYCIN; TELMISARTAN; TEMOZOLOMIDE; VACCINE;

ARTICLE; BIOTECHNOLOGY; CONSENSUS; DRUG APPROVAL; DRUG SCREENING; EUROPEAN UNION; ORGANIZATION; PRIORITY JOURNAL; RISK FACTOR;

EID: 17144414136     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2004.02320.x     Document Type: Article

References (8)

1. Garattini S. Bertele'V. Efficacy, safety and cost of new anticancer drugs. BMJ 2002; 325: 269-71.
2. Garattini S. Bertele'V. Efficacy, safety and cost of new drugs acting on the central nervous system. Eur J Clin Pharmacol 2003; 59: 79-84.
3. Garattini S. Bertele'V. Efficacy, safety and cost of new cardiovascular drugs: a survey. Eur J Clin Pharmacol 2003; 59: 701-6.
4. International Society of Drugs Bulletins declaration 2001: http:// www.isdbweb.org/.
5. EMEA 2003 European Public Assessment Reports, http:// www.emea.eu.int/index/indexh1.htm.
6. Gilbert D, Walley T, New B. Lifestyle medicines. BMJ 2000; 321: 1341-4.
7. Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001; 69: 89-95.
8. Marks K, Gulick RM. New antiretroviral agents for the treatment of HIV infection. Curr Infect Dis Rep 2004; 6: 333-9.